YOU’RE EXPERTS ON GPP
TREATMENT. WE’RE EXPERTS
ON ACCESSING IT.
inter-flare, we’re here to help make getting your patients on SPEVIGO as
seamless as possible.
The SPEVIGO Patient Support Program offers comprehensive, end-to-end assistance throughout the treatment journey.
Enrollment
After an introductory welcome call, dedicated experts perform a benefits investigation and update the patient on coverage.
- Download and complete pages 1-3 of the Enrollment Form
- Attach a copy of the patient’s insurance card (front and back)
- Fax to 1-855-237-0134
OR
Pre-approval
The SPEVIGO Patient Support Program and Field Reimbursement Managers help your office navigate reimbursement and learn about available patient support resources.
Approval of SPEVIGO (IV)
The SPEVIGO Patient Support Program notifies the patient of the infusion location and prepares them for the infusion.
Post-treatment
A Clinical Nurse Educator follows up with the patient post infusion and supports with transition to maintenance treatment.
Below are other resources offered to get your patients started:
LOCATOR
Infusion Site Locator Tool for SPEVIGO
Find an infusion center near your patient to begin SPEVIGO treatment.
Checklists and sample documentation to help your office respond to prior authorization requirements and denials
- Prior Authorization Tips and Checklist (opens in a new tab)
- Financial Assistance Flashcard (opens in a new tab)
- Sample Letter of Appeal (opens in a new tab)
- Sample CMS 1500 Form (opens in a new tab)
- Sample CMS 1450 Form (opens in a new tab)
- GPPPGA Scoring Tool (opens in a new tab)
- Sample Letter of Medical Necessity (opens in a new tab)
- Sample Letter of Emergency Use (opens in a new tab)
- HCP Infusion Center Checklist (opens in a new tab)
- Billing and Coding (opens in a new tab)
- SPEVIGO (IV) Patient Access Kit (opens in a new tab)
Next steps after treatment
Initiate maintenance treatment with SPEVIGO (SC)
Financial assistance with SPEVIGO
SPEVIGO Copay Programa
Commercially insured patients may pay as little as $0 per prescription.
SPEVIGO Patient Assistance Programa
For eligible patients with financial hardship and limited or no prescription coverage.
How to get started with SPEVIGO (IV)
There are multiple ways of accessing SPEVIGO (IV), including resources to assist you and your office throughout the process.
Direct to SPEVIGO Patient Support
Phone: 1-833-SPEVIGO (733-8446)
Fax: 1-855-237-0134
Email: Program@SpevigoPatientSupport.com
Direct to Specialty Pharmacy

Phone: 1-877-807-0812
Fax: 1-888-302-1028
Direct to Specialty Distributor

Specialtyb:
Phone: 1-855-855-0708
Fax: 1-614-553-6301
Email: specialtyonline@cardinalhealth.com
Specialty PR:
Phone: 1-787-625-4200
Fax: 1-787-625-4398
Email: cuserv@cardinalhealth.com

Phone: 1-800-746-6273
Fax: 1-800-547-9413
Email: service@asdhealthcare.com

Plasma and Biologics:
Phone: 1-877-625-2566
Fax: 1-888-752-7626
Email: mpborders@mckesson.com
Specialty Distribution:
Phone: 1-855-477-9800
Fax: 1-800-800-5673
Email: mshcustomercare-mspl@mckesson.com
MedSurge:
Phone: 1-855-571-2100
Email: customerservice@mckesson.com
bEmergency delivery service for expedited product shipping may be available.
Coding and Billing
CODING FOR SPEVIGO (IV)
| Code Type | Code | Description |
|---|---|---|
| ICD-10-CM | L40.1 | Generalized pustular psoriasis |
| HCPCS | J1747 | Injection, spesolimab-sbzo, 1 mg Modifier: Add JA to indicate IV administration |
These codes are not all-inclusive; appropriate codes can vary by patient, site of care, and payer. Correct coding is the responsibility of the provider submitting the claim for item or service. Please check with the payer to verify codes and billing requirements. LEO Pharma does not make any representation or guarantee concerning reimbursement or coverage for any service or item.
Additional Resources
CMS, Centers for Medicare & Medicaid Services; GPPPGA, Generalized Pustular Psoriasis Physician Global Assessment; HCP, healthcare professional; HCPCS, Healthcare Common Procedural Coding System; ICD-10-CM, International Classification of Diseases, 10th Revision, Clinical Modification; IV, intravenous; SC, subcutaneous.
The SPEVIGO Patient Support Program offers comprehensive, end-to-end assistance throughout the treatment journey.
Enrollment
After an introductory welcome call, dedicated experts perform a benefits investigation and update the patient on coverage.
- Download and complete pages 1-3 of the Enrollment Form
- Attach a copy of the patient’s insurance card (front and back)
- Fax to 1-855-237-0134
OR
Pre-approval
The SPEVIGO Patient Support Program and Field Reimbursement Managers help your office navigate reimbursement and learn about available patient support resources.
Approval of SPEVIGO (SC)
Once approved, a Clinical Nurse Educator coordinates with the office or the patient to schedule Virtual Injection Training, walking through proper technique before the first dose.
Post-treatment
The SPEVIGO Patient Support Program continues to support the office with reimbursement questions and connects patients to financial assistance programs throughout treatment.
Below are other resources offered to get your patients started:
Checklists and sample documentation to help your office respond to prior authorization requirements and denials
- Prior Authorization Tips and Checklist (opens in a new tab)
- Financial Assistance Flashcard (opens in a new tab)
- Sample Letter of Appeal (opens in a new tab)
- Sample CMS 1500 Form (opens in a new tab)
- Sample CMS 1450 Form (opens in a new tab)
- GPPPGA Scoring Tool (opens in a new tab)
- Sample Letter of Medical Necessity (opens in a new tab)
- Sample Letter of Medical Exception (opens in a new tab)
- Billing and Coding (opens in a new tab)
- SPEVIGO (SC) Patient Access Kit (opens in a new tab)
Financial assistance with SPEVIGO
SPEVIGO Copay Programa
Commercially insured patients may pay as little as $0 per prescription.
SPEVIGO (SC) Bridge Programa
The SPEVIGO (SC) Bridge Program may provide a free limited supply of SPEVIGO (SC) to eligible patients experiencing a coverage delay (7+ days) or denial.
SPEVIGO Patient Assistance Programa
For eligible patients with financial hardship and limited or no prescription coverage.
How to get started with SPEVIGO (SC)
There are multiple ways of accessing SPEVIGO (SC), including resources to assist you and your office throughout the process.
Direct to SPEVIGO Patient Support
Phone: 1-833-SPEVIGO (733-8446)
Fax: 1-855-237-0134
Email: Program@SpevigoPatientSupport.com
Direct to Specialty Pharmacy

Phone: 1-877-807-0812
Fax: 1-888-302-1028
Direct to Specialty Distributor

Specialtyb:
Phone: 1-855-855-0708
Fax: 1-614-553-6301
Email: specialtyonline@cardinalhealth.com
Specialty PR:
Phone: 1-787-625-4200
Fax: 1-787-625-4398
Email: cuserv@cardinalhealth.com

Phone: 1-800-746-6273
Fax: 1-800-547-9413
Email: service@asdhealthcare.com

Plasma and Biologics:
Phone: 1-877-625-2566
Fax: 1-888-752-7626
Email: mpborders@mckesson.com
Specialty Distribution:
Phone: 1-855-477-9800
Fax: 1-800-800-5673
Email: mshcustomercare-mspl@mckesson.com
MedSurge:
Phone: 1-855-571-2100
Email: customerservice@mckesson.com
bEmergency delivery service for expedited product shipping may be available.
Coding and Billing
CODING FOR SPEVIGO (SC)
| Code Type | Code | Description |
|---|---|---|
| ICD-10-CM | L40.1 | Generalized pustular psoriasis |
| HCPCS | J1747 | Injection, spesolimab-sbzo, 1 mg Modifier: Add JB to indicate SC administration |
These codes are not all-inclusive; appropriate codes can vary by patient, site of care, and payer. Correct coding is the responsibility of the provider submitting the claim for item or service. Please check with the payer to verify codes and billing requirements. LEO Pharma does not make any representation or guarantee concerning reimbursement or coverage for any service or item.
Additional Resources
CMS, Centers for Medicare & Medicaid Services; GPPPGA, Generalized Pustular Psoriasis Physician Global Assessment; HCP, healthcare professional; HCPCS, Healthcare Common Procedural Coding System; ICD-10-CM, International Classification of Diseases, 10th Revision, Clinical Modification; IV, intravenous; SC, subcutaneous.